Work

Neoadjuvant mitomycin C plus carboplatin followed by paclitaxel vs. standard doxorubicin–cyclophosphamide followed by paclitaxel–carboplatin in BRCA1/2-associated breast cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.620

Authors: Petr Krivorotko, Evgeny Imyanitov, Diana Enaldieva, Anna Sokolenko, Roman Donskih, Larisa Gigolaeva, Arina Gorina, Mariam Dzhelialova, Tatiana Semiglazova, Vladimir Semiglazov

Institutions: Institute of Oncology NN Petrov, Ministry of Health of the Russian Federation

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162526795

Cites:

Cited by:

Related to: